Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

(2013) Frank van den Hoogen et al.   ANNALS OF THE RHEUMATIC DISEASES

HLA Markers for Poor Prognosis in Systemic Sclerosis Brazilian Patients

(2013) Ana Paula Toledo Del Rio et al.   DISEASE MARKERS

The Geography of Recent Genetic Ancestry across Europe

(2013) Peter Ralph et al.   PLOS BIOLOGY

The Conditional Nature of Genetic Interactions: The Consequences of Wild-Type Backgrounds on Mutational Interactions in a Genome-Wide Modifier Screen

(2013) Sudarshan Chari et al.   PLoS Genetics

Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement

(2012) Gabriele Valentini et al.   ARTHRITIS RESEARCH & THERAPY

Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis

(2011) L. Beretta et al.   RHEUMATOLOGY

Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups

(2010) Hiroe Sato et al.   HUMAN MOLECULAR GENETICS

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls

(2009) F. C. Arnett et al.   ANNALS OF THE RHEUMATIC DISEASES

Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis

(2008) Martial Koenig et al.   ARTHRITIS AND RHEUMATISM